Abstract #2307
The effects of Dorzolamide on retinal and choroidal blood flow in a mouse glaucoma model
Saurav B Chandra 1 , Kaiwalya S Deo 1 , Eric R Muir 1 , Jeffrey W Kiel 2 , and Timothy Q Duong 1
1
Research Imaging Institute, UT Health Sc.
Center, San Antonio, San Antonio, Texas, United States,
2
Ophthalmology,
UT Health Sc. Center, San Antonio, San Antonio, Texas,
United States
Dorzolamide (DZ) is clinically used to treat glaucoma by
reducing intraocular pressure, which could affect blood
flow to the eye. The goal of this study was to
investigate the effect of topical DZ application on
retinal and choroidal blood flow in DBA/2J mice, an
established mouse model of glaucoma at different stages
of severity. DZ was found to induce measurable and
sustained effects in choroidal BF and retinal BF at up
to 2 hours post DZ application in late stage glaucoma
mice.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
